Get started

LLY

PFE Large Cap Pharma increased its dividendPFE just raised its dividend On the chart it has been trending downward as shown also by a down sloping anchored VWAP bands. Price is currently sitting at long term support and two standard deviations below VWAP. It appears to be ready to reverse from the deep undervalued area. In confirmation, teh voume indicator shows moderate increased relative volume compared with March. I see this as a good opportunity to enter a swing long trade or investment. PFE has its increased dividend as a hint to shareholders of increasing earnings also with the next generation of COVID vaccines in the pipeline along with a diversified line of other products. The only thing that will slow PFE down in federal legislation to limit the retail MSRP prices of its products to all consumers including those with no insurance and commercial coverage outside federal programs. PFE is solid as a rock. I see the buy signal.
NYSE:PFELong
by AwesomeAvani
2
LLY - Rising Trend Channel [Mid Term]- LLY is in a rising trend channel in the medium long term. - LLY has also received a positive signal from the moving average indicator, thus signaling a continued rise. - LLY has broken up through resistance at 375. - The short term momentum of the stock is strongly positive, with RSI above 70. - Overall assessed as technically positive for the medium long term. *EP: Enter Price, SL: Support, TP: Take Profit, CL: Cut Loss, TF: Time Frame, RST: Resistance, RTS: Resistance to be Support LT TP: Long Term Target Price *Chart Pattern: DT - Double Top | BEARISH | RED DB - Double Bottom | BULLISH | GREEN HNS - Head & Shoulder | BEARISH | RED REC - Rectangle | BLUE iHNS - inverse head & Shoulder | BULLISH | GREEN Verify it first and believe later. WavePoint ❤️
NYSE:LLYLong
by wavepoint99
ELI LILLY on the best buy opportunity of the year!Eli Lilly and Company (LLY) has been trading within a Channel Up pattern since the October 30 2020 low exactly on the 1W MA100 (red trend-line). As the 1D RSI turned oversold below the 30.00 barrier, while the price touched the bottom (Higher Lows trend-line) of the Channel Up, it has filled all conditions for the most optimal buy level of the year. There have been another three similar oversold events, each on one year since 2020. Once the price breaks above the 1D MA200 (orange trend-line) again, which you can use as confirmation and take the buy after it, we'll set a target at $390.00 on a 4 month horizon. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:LLYLong
by TradingShot
2
MSFT SHORT study(title="BestIntradayTips", shorttitle="BIT", precision=0, overlay=true, scale=scale.left) trendDetectionLength=input(2) showDistributionBelowZero=input(false, type=bool) mov = close>close ? 1 : close= dif wave=(trend != nz(wave )) and isTrending ? trend : nz(wave ) vol=wave==wave ? (nz(vol )+volume) : volume up=wave == 1 ? vol : 0 dn=showDistributionBelowZero ? (wave == 1 ? 0 : wave == -1 ? -vol : vol) : (wave == 1 ? 0 : vol) input_src         = wave == 1 ? vol : 0 input_ma_period   = input(50, title="Moving average") input_max_height  = input(1000, title="Maximum value on left bar") ma                = sma(input_src, input_ma_period) normalized_volume = min(input_src / ma * 100, input_max_height * 1) plot(input_max_height, transp=100, title="") // input_src1         = showDistributionBelowZero ? (wave == 1 ? 0 : wave == -1 ? -vol : vol) : (wave == 1 ? 0 : vol) input_ma_period1  = input(50, title="Moving average") input_max_height1  = input(1000, title="Maximum value on left bar") hline(0) hline(250) hline(500) hline(750) ma1                = sma(input_src1, input_ma_period1) normalized_volume1 = min(input_src1 / ma1 * 100, input_max_height1 * 1) resCustom = input(title="Timeframe", type=resolution, defval="1440" ) v=security(tickerid, resCustom,normalized_volume) resCustom1 = input(title="Timeframe", type=resolution, defval="1440" ) v1=security(tickerid, resCustom,normalized_volume1) a=v>0 and v1<50 b=v1>0 and v<50 bgcolor(a > 0 ? blue : na, transp=80) bgcolor(b > 0 ? red : na, transp=80)
NSE:LICI
by khaireakshay94
Eli Lilly up and up. LLYShort term and temporarily. Immediate targets 257, 263, 272. Invalidation 232. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
NYSE:LLYLong
by Rykin_Capital
$BIIB: Update, get long!I think it warrants making a new publication here, $BIIB has flashed a buy signal with tremendously good reward to risk, as it can resume the long term trend that can take it over $1600-2600 over time. Phase 3 clinical trials have gone really well for their Alzheimer's treatment 'Aduhelm', putting it in line with results obtained by $LLY's drug 'Donanemab'. I was long $LLY and have been trading in and out of $BIIB trying to time the end of the long slide since the FDA approval news came out. I think the time is now, to get in and sit tight. I've banked my $LLY exposure, but both companies will likely do well with their Alzheimer's treatments going forward and have solid trends, but the reward to risk favors $BIIB, so I'm only long Biogen currently. Best of luck! Cheers, Ivan.
NASDAQ:BIIBLong
by IvanLabrie
Flat on Eli Lilly. LLYWe are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
NYSE:LLYShort
by Rykin_Capital